Biogen (BIIB) PT Lowered to $285 at Jefferies

February 14, 2024 7:55 AM EST
Get Alerts BIIB Hot Sheet
Price: $209.15 -0.32%

Rating Summary:
    28 Buy, 15 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Jefferies analyst Michael Yee lowered the price target on Biogen (NASDAQ: BIIB) to $285.00 (from $300.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change